Exhaled nitric oxide in chronically ventilated preterm infants

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 89, Issue 1, 2004, Pages

  Williams, O ^a   Bhat, R Y ^a   Cheeseman, P ^a   Rafferty, G F ^a   Hannam, S ^a   Greenough, A ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; NITRIC OXIDE;

ARTICLE; ARTIFICIAL VENTILATION; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CORRELATION ANALYSIS; EXPIRED AIR; GESTATIONAL AGE; HUMAN; LONG TERM CARE; NEWBORN; OXYGEN CONCENTRATION; PREMATURITY; PRIORITY JOURNAL;

EID: 1642533658     PISSN: 00039888     EISSN: 13592998     Source Type: Journal    
DOI: 10.1136/fn.89.1.f88     Document Type: Article

References (9)

1. Vyas JR, Currie AE, Skuker DEG, et al. Concentration of nitric oxide products in bronchoalveolar fluid obtained from infants who develop chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 1999;81:F217-20.
2. Schedin U, Norman M, Gustafsson LE, et al. Endogenous nitric oxide in the upper airways of premature and term infants. Acta Paediatr 1997;86:1229-1235.
3. Baraldi E, Azzolin NM, Zanconato S, et al. Corticosteroids decrease exhaled nitric oxide in children with acute asthma. J Pediatr 1997;131:381-5.
4. Archer S. Measurement of nitric oxide in biological models. FASEB J 1993;7:349-60.
5. Artlich A, Busch T, Lewandowski K, et al. Exhaled nitric oxide in preterm infants. Respir Physiol 1998;114:195-200.
6. Hird M, Greenough A, Gamsu H. Gas trapping during high frequency positive pressure ventilation using conventional ventilators. Early Hum Dev 1990;22:51-6.
7. Tsuchuya M, Tokai H, Takehara Y, et al. Interrelation between oxygen tension and nitric oxide in the respiratory system. Am J Respir Crit Care Med 2000;162:1257-61.
8. Hall G, Reinmann B, Wildhaber J, et al. Tidal exhaled nitric oxide in healthy, unsedated newborn infants with prenatal tobacco exposure. J Appl Physiol 2002;92:59-66.
9. Korhonen R, Lahti A, Hamalainen M, et al. Dexamethasone inhibits inducible nitric oxide synthase expression and nitric oxide production by destablising mRNA in lipopolysaccharide treated macrophages. Mol Pharmacol 2002;62:698-704.